# Molbio Diagnostics IPO opens today at Rs 768-807 per share

2026-08-10T01:45:39+00:00 | Business & Economy | Indian Opinion Desk

Corroboration: 1 independent outlet

Molbio Diagnostics' IPO opens today at Rs 768-807 per share to raise up to Rs 940 crore. The company makes the Truenat portable diagnostic platform, endorsed by WHO for tuberculosis testing and patented in over 100 countries. For FY26, it posted revenue of Rs 1,445 crore and net profit of Rs 164 crore, with over 80% of revenue from government and international aid agencies. Its top five customers contribute more than half of revenue, signalling concentration risk. Anchor investors including Goldman Sachs and BlackRock have already taken up Rs 281.5 crore. Brokerages recommend subscription for the long term, though valuation at 57 times earnings is steep. The grey market suggests a 16% listing gain, according to Mint.

## Coverage

- economictimes.indiatimes.com <https://economictimes.indiatimes.com/markets/ipos/fpos/can-molbio-diagnostics-ipo-deliver-long-term-growth-for-high-risk-investors/articleshow/133076987.cms>
- thehindubusinessline.com <https://www.thehindubusinessline.com/markets/molbio-diagnostics-ipo-what-brokerages-say-buy-or-avoid/article71324539.ece>
- livemint.com <https://www.livemint.com/market/ipo/molbio-diagnostics-ipo-gmp-molbio-diagnostics-ipo-anchor-round-molbio-diagnostics-ipo-review-molbio-diagnostics-ipo-11786329424313.html>

Tags: diagnostics, IPO, Molbio Diagnostics, stock market, Truenat, tuberculosis
Canonical: https://indianopinion.org/molbio-diagnostics-ipo-to-raise-rs-940-crore-reduce-promoter-stake/
License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources.
Cite: https://indianopinion.org/molbio-diagnostics-ipo-to-raise-rs-940-crore-reduce-promoter-stake/#story-in-brief

Review state: restored archive article, accurate at time of publication, not offered to search indexes.